Back to search

Article

Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition

2025-04-15

Abstract excerpt

Poly (ADP-ribose) polymerase inhibitors (PARPi) are standard of care for many BRCA1 deficient cancers, though few cures are achieved. We sought to determine if targeting the protection of the single-strand DNA gaps induced by PARPi in BRCA-deficient cancers could increase efficacy. Replication protein A (RPA) participates in critical protein-protein and protein-DNA interactions to protect single-stranded DNA (ssDN...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32e1e6ea-b75c-5708-9f13-d247f093972e
DOI
10.1101/2025.04.09.647957
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibitionDOI 10.1101/2025.04.09.647957
Select a neighboring publication to make it the new centre.